Comparison of results obtained using the two approaches suggested three common proteins, including one favorable target, YARS, and two unfavorable targets, KIAA1522 and PDCD6, as the most reliable proteins to predict chemotherapeutic responses in breast cancer (Fig. 2b). Here, YARS1 is linked to breast carcinoma.